163 related articles for article (PubMed ID: 26694163)
1. Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma.
Janiszewska J; Szaumkessel M; Kostrzewska-Poczekaj M; Bednarek K; Paczkowska J; Jackowska J; Grenman R; Szyfter K; Wierzbicka M; Giefing M; Jarmuz-Szymczak M
PLoS One; 2015; 10(12):e0144924. PubMed ID: 26694163
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
[TBL] [Abstract][Full Text] [Related]
3. Loss of the MAF Transcription Factor in Laryngeal Squamous Cell Carcinoma.
Janiszewska J; Bodnar M; Paczkowska J; Ustaszewski A; Smialek MJ; Szylberg L; Marszalek A; Kiwerska K; Grenman R; Szyfter K; Wierzbicka M; Giefing M; Jarmuz-Szymczak M
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356658
[TBL] [Abstract][Full Text] [Related]
4. [Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma].
Hu A; Jin X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):788-92. PubMed ID: 23259291
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑503 serves an oncogenic role in laryngeal squamous cell carcinoma via targeting programmed cell death protein 4.
Shuang Y; Zhou X; Li C; Huang Y; Zhang L
Mol Med Rep; 2017 Oct; 16(4):5249-5256. PubMed ID: 28849168
[TBL] [Abstract][Full Text] [Related]
6. Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.
Lapa RML; Barros-Filho MC; Marchi FA; Domingues MAC; de Carvalho GB; Drigo SA; Kowalski LP; Rogatto SR
Oral Oncol; 2019 Jun; 93():76-84. PubMed ID: 31109699
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma.
Xiao X; Zhou L; Cao P; Gong H; Zhang Y
Int J Oncol; 2015 Jan; 46(1):161-74. PubMed ID: 25309979
[TBL] [Abstract][Full Text] [Related]
8. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
Yungang W; Xiaoyu L; Pang T; Wenming L; Pan X
Biomed Pharmacother; 2014 Mar; 68(2):149-54. PubMed ID: 24055400
[TBL] [Abstract][Full Text] [Related]
9. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑195 inhibits cell proliferation, migration and invasion in laryngeal squamous cell carcinoma by targeting ROCK1.
Liu Y; Liu J; Wang L; Yang X; Liu X
Mol Med Rep; 2017 Nov; 16(5):7154-7162. PubMed ID: 28901478
[TBL] [Abstract][Full Text] [Related]
11. miR-196b is a prognostic factor of human laryngeal squamous cell carcinoma and promotes tumor progression by targeting SOCS2.
Zhao X; Zhang W; Ji W
Biochem Biophys Res Commun; 2018 Jun; 501(2):584-592. PubMed ID: 29753737
[TBL] [Abstract][Full Text] [Related]
12. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
[TBL] [Abstract][Full Text] [Related]
13. Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma.
Maia D; de Carvalho AC; Horst MA; Carvalho AL; Scapulatempo-Neto C; Vettore AL
J Transl Med; 2015 Aug; 13():262. PubMed ID: 26264462
[TBL] [Abstract][Full Text] [Related]
14. High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma.
Giefing M; Zemke N; Brauze D; Kostrzewska-Poczekaj M; Luczak M; Szaumkessel M; Pelinska K; Kiwerska K; Tönnies H; Grenman R; Figlerowicz M; Siebert R; Szyfter K; Jarmuz M
Genes Chromosomes Cancer; 2011 Mar; 50(3):154-66. PubMed ID: 21213369
[TBL] [Abstract][Full Text] [Related]
15. RNA-Seq profiling of circular RNAs in human laryngeal squamous cell carcinomas.
Lu C; Shi X; Wang AY; Tao Y; Wang Z; Huang C; Qiao Y; Hu H; Liu L
Mol Cancer; 2018 May; 17(1):86. PubMed ID: 29716593
[TBL] [Abstract][Full Text] [Related]
16. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
17. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.
Wang JL; Wang X; Yang D; Shi WJ
Yonsei Med J; 2016 Mar; 57(2):298-305. PubMed ID: 26847279
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.
Ayaz L; Görür A; Yaroğlu HY; Ozcan C; Tamer L
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1499-506. PubMed ID: 23817697
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma.
Geng J; Liu Y; Jin Y; Tai J; Zhang J; Xiao X; Chu P; Yu Y; Wang SC; Lu J; Han S; Shi J; Guo Y; Ni X
Oncol Rep; 2016 Apr; 35(4):2017-26. PubMed ID: 26883008
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
